Search arXiv⌕ Search

arXiv subjects

Mahdi Ait Lhaj Loutfi

Publications and source records attributed to Mahdi Ait Lhaj Loutfi.

2 recordsLinked to original sources

Reference Manual of MEDiml

Radiomics is the high-throughput extraction of quantitative features (e.g., tumor shape, intensity distributions, and texture) from medical images to characterize tissues and uncover disease patterns invisible to the human eye. These features can serve as candidate imaging biomarkers for cancer diagnosis, prognosis, and classification. However, extracting thousands of features makes it difficult to identify the most informative ones for a given clinical task, while implementing an end-to-end workflow can require programming expertise that limits accessibility for clinical researchers. Hence, we propose MEDiml, an open-source, standards-compliant radiomics platform connecting feature extraction, predictive modeling, and interpretation through complementary graphical and programmatic interfaces. MEDiml combines a Python package (MEDiml-pkg) with a graphical desktop application (MEDiml-app) that enables researchers to conduct experiments without writing code. Both interfaces use the same computational implementation, and code generation exports graphically configured workflows as executable Python code, facilitating reproducibility and collaboration between clinical researchers and computational scientists. A typical MEDiml workflow includes image preprocessing, radiomic feature extraction, feature set reduction, model training and evaluation, and interpretation using feature importance. Feature sets can be grouped into levels of radiomic complexity (morphological, intensity-based, textural, and filter-based) to evaluate whether more complex features provide additional predictive value. This reference manual documents the radiomics concepts, workflow, software components, architecture, and installation, compares MEDiml with existing tools, and demonstrates its complexity-driven workflow on five oncological imaging cohorts comprising 2,104 patients. Resources: www.mediml.app.

cs.SE↗

Unraveling Radiomics Complexity: Strategies for Optimal Simplicity in Predictive Modeling

Background: The high dimensionality of radiomic feature sets, the variability in radiomic feature types and potentially high computational requirements all underscore the need for an effective method to identify the smallest set of predictive features for a given clinical problem. Purpose: Develop a methodology and tools to identify and explain the smallest set of predictive radiomic features. Materials and Methods: 89,714 radiomic features were extracted from five cancer datasets: low-grade glioma, meningioma, non-small cell lung cancer (NSCLC), and two renal cell carcinoma cohorts (n=2104). Features were categorized by computational complexity into morphological, intensity, texture, linear filters, and nonlinear filters. Models were trained and evaluated on each complexity level using the area under the curve (AUC). The most informative features were identified, and their importance was explained. The optimal complexity level and associated most informative features were identified using systematic statistical significance analyses and a false discovery avoidance procedure, respectively. Their predictive importance was explained using a novel tree-based method. Results: MEDimage, a new open-source tool, was developed to facilitate radiomic studies. Morphological features were optimal for MRI-based meningioma (AUC: 0.65) and low-grade glioma (AUC: 0.68). Intensity features were optimal for CECT-based renal cell carcinoma (AUC: 0.82) and CT-based NSCLC (AUC: 0.76). Texture features were optimal for MRI-based renal cell carcinoma (AUC: 0.72). Tuning the Hounsfield unit range improved results for CECT-based renal cell carcinoma (AUC: 0.86). Conclusion: Our proposed methodology and software can estimate the optimal radiomics complexity level for specific medical outcomes, potentially simplifying the use of radiomics in predictive modeling across various contexts.

eess.IV↗